Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Johnson and Johnson...

    Johnson and Johnson found negligent in landmark vaginal mesh lawsuit in Australia

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-11-23T09:18:34+05:30  |  Updated On 16 Aug 2021 4:12 PM IST

    Australia's Federal Court found that Johnson and Johnson (JnJ) subsidiary Ethicon had sold the devices (pelvic mesh implants) without warning women about the "gravity of the risks", and was negligent in rushing the products to market before proper testing.


    New Delhi: More than 1,350 Australian women won a seven-year-old class action lawsuit on Thursday against Johnson & Johnson (JnJ) for misleading patients and surgeons about the risks of the pharmaceutical giant's pelvic mesh implants.


    The suit is one of many JnJ has faced in the United States, Canada and Europe over the implants, used to treat urinary incontinence and pelvic organ prolapse, in which organs shift from normal positions. JnJ in October agreed to pay nearly $117 million to resolve claims in 41 U.S. states and the District of Columbia.


    Australia's Federal Court found that JnJ subsidiary Ethicon had sold the devices without warning women about the "gravity of the risks", and was negligent in rushing the products to market before proper testing. The judge in the case, Anna Katzmann, has set February for the next hearing in the case, where damages will be discussed.


    Ethicon said it was reviewing the court's decision and would consider its options to appeal.


    "Ethicon believes that the company acted ethically and responsibly in the research, development and supply of these products," the company said in a statement.


    Judge Katzmann ruled that much of the information the company provided about the devices were "inaccurate" and at times made "false representations".


    "The question is whether this conduct considered as a whole was misleading or likely to mislead. I believe it was," Katzmann said in her judgment.


    "The post-market evaluation of all the Ethicon devices was deficient," she said. "It fell well below the level of care required of a reasonably prudent manufacturer."


    "The risks were known, not insignificant and on Ethicon's own admission, serious harm could ensue if they eventuated," the judge said in her ruling.


    Patients said they had suffered chronic pain, bleeding and severe discomfort during sexual intercourse after having the mesh surgically implanted. Dozens of women involved in the class action welcomed the court's decision.


    Read Also: Johnson and Johnson seeks European Medicines Agency nod for Ebola Vaccine


    Julie Davis, the original claimant in the case, said she was "incredibly pleased" with the judgment but said it would not take away the pain and damage done to women.


    "They have treated women essentially like guinea pigs, lied about it and done nothing to help," she told reporters at a televised media conference outside the court in Sydney.


    Read Also: Johnson and Johnson wins EMA vote for depression drug Spravato

    AustraliaEthiconJnJJnJ implantsJohnson n Johnsonpelvic meshpelvic organ prolapseurinary incontinencevaginal mesh
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok